Atlas Trials

Beneficial Effect of Insulin Glulisine by Lipoatrophy and Type 1 Diabetes (LAS)

Clinical trial NCT02914886 · COMPLETED

Trial details

NCT number
NCT02914886
Sponsor
Kinderkrankenhaus auf der Bult
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Type 1 DiabetesLipoatrophy
Start date
2016-09-01
Primary completion
2019-04-01
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.